Addiction Clinical Trial
Official title:
Effects of Repetitive tDCS on ad Libitum Smoking Behavior: An EMA and EEG Study
Bilateral (left cathodal/ right anodal) transcranial Direct Current Stimulation (tDCS) over
the dorsolateral prefrontal cortex (DLPFC) seems to reduce craving and to increase the time
till smoking the first cigarette after the intervention. The current study explores whether
actual cigarette consumption decreases after repetitive tDCS. Cigarette consumption and
craving will therefore be measured by means of EMA, before (at baseline), during and after
multiple tDCS sessions, and at 3 months follow-up.
To study the working mechanism behind the effects of tDCS, electrophysiological responses
(ERPs) and behavioral measures of cognitive control functioning will be taken into account at
baseline, one day after the last tDCS session and at three months follow up.
We hypothesize that cigarette consumption will decrease after repetitive tDCS, and that this
effect is associated with better cognitive control functioning.
The proposed experiment is a double-blind randomized placebo-controlled trial. 60 smokers
will be randomly assigned to two conditions, namely tDCS or sham (placebo).
Participants will receive real tDCS or sham for three days in one week. The interventions
contain twice daily sessions for 13 minutes with an interval of 20 min. Moreover, on the
first treatment day and the day after the treatment week, participants complete a number of
questionnaires, and perform two psychological tasks (a gambling task and the Go/NoGo task) to
measure cognitive control functioning (e.g. risky decision making and inhibitory control
respectively). During these tasks, event-related potentials will be recorded by means of EEG.
After three months, participants are asked to return to fill out the same questionnaires and
perform the same psychological tasks as before, to measure the lasting effect of tDCS. During
this last session, event-related potentials will also be recorded. In addition, carbon
monoxide levels will be measured on all days where subjects perform the tasks.
EMA:
For three weeks, starting the week before tDCS treatment, participants are asked to log every
cigarette before they smoke one. During these weeks, participants complete EMA questionnaires
on their mobile phone about cigarette consumption, craving, and affect that will take
approximately 5 minutes. The EMA questionnaire will be presented four times daily on a
quasi-random basis. Finally, during end-of-day assessments participants have the possibility
to indicate any missed cigarettes. At three months follow-up, participants are asked to
undergo the same EMA procedure for one more week, to study the lasting effects of tDCS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Completed |
NCT04110626 -
Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
|
||
Completed |
NCT03007940 -
Using NIATx Strategies to Implement Integrated Services in Routine Care
|
N/A | |
Not yet recruiting |
NCT04030858 -
The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery
|
N/A | |
Completed |
NCT03347643 -
The Effectiveness of tDCS on Internet Game Addiction
|
Phase 2 | |
Active, not recruiting |
NCT02836080 -
Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)
|
N/A | |
Completed |
NCT03221985 -
ESM Pilot: Mobile Phones and Psychology
|
N/A | |
Completed |
NCT02556060 -
Lamotrigine for Ketamine Dependence Trial
|
Phase 2/Phase 3 | |
Completed |
NCT01531153 -
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
|
N/A | |
Completed |
NCT02812810 -
Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence
|
N/A | |
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
Completed |
NCT04409106 -
The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
|
||
Not yet recruiting |
NCT06459609 -
Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment
|
N/A | |
Recruiting |
NCT05595759 -
Violence Against Women in Patients With Alcohol Substance Addiction Training
|
N/A | |
Completed |
NCT04099173 -
A Brief Mindfulness-Based Intervention for Suicidal Ideation
|
N/A | |
Recruiting |
NCT04959643 -
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
|
||
Completed |
NCT04133688 -
Mobile App in Addiction
|
N/A | |
Recruiting |
NCT04063267 -
Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder
|
Phase 2 | |
Completed |
NCT05114577 -
Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery
|
N/A | |
Terminated |
NCT02671240 -
Prognosis of Behavioral Addiction in Parkinson's Disease
|